Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers
about
Clinical review: Traumatic brain injury in patients receiving antiplatelet medicationClopidogrel and hip fractures, is it safe? A systematic review and meta-analysisClopidogrel for the secondary prevention of strokeClopidogrel: an updated and comprehensive reviewRole of Siglec-7 in apoptosis in human platelets.Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation.Antiplatelet agents and proton pump inhibitors - personalizing treatment.Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties.Is Taking an Antiplatelet Agent a Contraindication for Early Surgery in Displaced Femur Neck Fracture?A survey of the peri-operative management of urological patients on clopidogrel.Antiplatelet drugs and the perioperative period: What every urologist needs to knowP2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.Platelet P2Y12 receptor inhibition by thienopyridines: status and future.Clopidogrel Within Few Hours of Coronary Artery Bypass Grafting Does Significantly Increase the Risk of Bleeding.Prevention and management of TURP-related hemorrhage.Antiplatelet therapy in acute coronary syndromes.Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents.Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside.Percutaneous native kidney biopsy in patients receiving antiplatelet agents- is it necessary to stop them routinely?Ticagrelor for the treatment of atherosclerotic disease: insights from the PARTHENON clinical development program.Delayed caroticocavernous fistula after stent-assisted coil embolization of intracavernous carotid aneurysm: should we manage conservatively?Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel.Clopidogrel: cardiologists' panacea or neurologists' headache?Right middle cerebral artery aneurysm posted for clipping on dual anti-platelet therapy.To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question.Expression of EMMPRIN (CD147) on circulating platelets in vivo.Peri-operative management of anti-platelet agents.Antiplatelet drugs in elective ENT surgery.Withholding clopidogrel for 3 to 6 versus 7 days or more before surgery in hip fracture patients.Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation.Not all statins interfere with clopidogrel during antiplatelet therapy.Aspirin and clopidogrel use in the perioperative period for non-cardiac surgery.Single nucleotide polymorphism of CYP3A5*3 contributes to clopidogrel resistance in coronary artery disease patients among Tamilian population.Relationship between maximum clot firmness in ROTEM® and postoperative bleeding after coronary artery bypass graft surgery in patients using clopidogrel.
P2860
Q26830409-C075AE4A-4FA8-43DC-9C27-EBA76B2CA459Q28068229-26202496-8C46-4B76-B62D-95F170CE48D8Q28176560-A25CE154-550A-4739-84D1-C8B07357A7FDQ28219411-6D002F36-E9AD-4DF3-B60C-7522BD8D5046Q35258847-F5F79D52-695F-4A67-94FA-DD558FE3C157Q35291798-CD78F934-F804-429B-A14A-2CA3562F07F8Q36441481-974EAC00-DB85-45BE-A872-1D4FE7BCD90BQ37115439-B0DCB539-18C4-48D6-BA3F-3249B707F204Q37150149-3B1076FA-97B0-4CFE-8229-6E527D2EF5F0Q37358726-889CF78C-3C1B-43AA-B340-C9FFA44160CEQ37427253-A73503B7-346A-48AE-AE93-02BA504D0FA9Q37562606-8BC6E9FC-012D-4DB9-B615-CB4BCB478931Q37579228-1CF1C321-5888-4D22-990D-4E9E252209CDQ37711258-F285994E-3926-4AE5-B16B-87CFD5D310CEQ37918319-CC847AF5-2C56-45F9-9FED-E55096C21A2AQ37965609-0AB3E908-0D00-4CB4-A04B-7ECFB09769A2Q37997017-4045F4CB-0279-495A-B5A6-51392792B9EBQ38165873-FF251D5E-BA69-4AB1-96F5-CF722DE587D5Q38523257-5EA2A50F-630B-4770-9A0F-DDABF2CB7122Q38869502-8C4FECBB-D1A7-4D4E-93FE-0B97FC029BB3Q39972508-936DC3CC-ADDF-420B-96CD-589693004790Q40161287-1D14C9F6-F808-4CF9-832B-5B82266CA3E6Q40393685-D88D369B-56BC-4B6A-8B02-E45A971F0A0BQ40765798-E7597E85-A669-4128-A9E1-EDDAA414143DQ42373768-40A272E2-C479-41C0-AD62-9E9050EFB6F0Q43227478-C9FE533A-1DB4-4C91-A4B7-E4F2716F5105Q43289049-879A6DBB-8153-44C9-99AB-C61A5C2CB590Q43839301-73F52BD5-6F7D-4542-A11C-96A0576F1BAAQ44787178-0D4FAFA9-2DCD-444F-8208-480A69A65D63Q45729496-E9FFE101-7D61-478C-BD4D-921C14A19540Q46651379-E66736E2-51D6-4C9B-A142-E44D0037EA53Q46738760-E58B5279-950E-4145-BC82-8E9C629BB2EDQ54195220-508C1BB9-FBF1-4094-991F-579D451F650DQ55379102-F2F3EF33-2992-4B4C-B451-A486AE5D10C8
P2860
Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Recovery of platelet function ...... reatment in healthy volunteers
@ast
Recovery of platelet function ...... reatment in healthy volunteers
@en
Recovery of platelet function ...... reatment in healthy volunteers
@nl
type
label
Recovery of platelet function ...... reatment in healthy volunteers
@ast
Recovery of platelet function ...... reatment in healthy volunteers
@en
Recovery of platelet function ...... reatment in healthy volunteers
@nl
prefLabel
Recovery of platelet function ...... reatment in healthy volunteers
@ast
Recovery of platelet function ...... reatment in healthy volunteers
@en
Recovery of platelet function ...... reatment in healthy volunteers
@nl
P2093
P2860
P3181
P1476
Recovery of platelet function ...... reatment in healthy volunteers
@en
P2093
P2860
P3181
P356
10.1046/J.0306-5251.2001.01453.X
P407
P577
2001-09-01T00:00:00Z